Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 870 results for "glenmark"

USFDA approves Glenmark's fungal infections treatment drug
DNA

Glenmark gets USFDA nod for fungal infections treatment drug

Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for Voriconazole Tablets, used to treat fungal infections. "Glenmark Pharmaceuticals Inc., USA has been granted final approval by the US Food & Drug Administration ... Economic Times, 8 hours ago
[x]  
MedIndia

Phase I Clinical Studies For Antibody to Treat Autoimmune Disease Completed by Glenmark

Phase I clinical studies has been completed by Glenmark Pharmaceuticals for their novel monoclonal antibody 'GBR 830' for treating autoimmune diseases. While phase I trials took place in the Netherlands, the company said it will initiate the ...
 MedIndia4 hours ago Glenmark Pharmaceuticals completes clinical Phase 1 studies for GBR 830  Business Standard1 day ago Glenmark completes phase I clinical trials for antibody  Business Standard1 day ago
India Infoline

Glenmark Pharma drops 14.23% in seven sessions

d 3.7% to Rs 1,027.30 at 10:55 IST on BSE, with the stock extending previous six sessions' 10.94% losses. Meanwhile, the BSE Sensex was down 468.64 points, or 1.82%, to 25,296.14. On BSE, so far 69,380 shares were traded in the counter, compared with an ...
 Business Standard8 hours ago Glenmark Pharma scales record high  Business Standard2 weeks ago BSE Pharma index hits lifetime high  Business Standard2 weeks ago Coal India, Glenmark Pharma among 36 stocks that hit 52-week high  India Infoline2 months ago

Stocks in news: Wipro, Cipla, Jyothy Lab, Glenmark, Leyland

Wipro | Cipla | Jyothy Labs | Edelweiss Financial | Power Finance Corporation | Pfizer | NBCC | Power Mech | Glenmark Pharma | NMDC | Ashok Leyland | SBI | Raymond and Gayatri Projects are stocks, which are in the news today.
 Money Control12 hours ago
Money Today

Stocks in news: Jyothy Labs, Glenmark and more

New Delhi Last Updated: September 4, 2015 | 08:59 IST Photo: Reuters With the Asian markets in negative and China's stock markets remaining closed for the second day, here are the five stocks likely to be in focus today: Ashok Leyland:Reserve Bank of India ...
 Money Today4 hours ago Markets remain under pressure  Equitymaster.com3 days ago Power punch: 15 midcaps that outperformed market crash  MSN News US4 days ago Indian markets rebound  Equitymaster.com1 week ago
[x]  
First Post.com

Overweight Indian pharma stocks defy Asian market rout. Here's why

So far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy's 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent The post Overweight Indian pharma stocks defy Asian market rout. Here’s why appeared first on Firstpost .
 First Post.com1 day ago Indian pharma stocks lure smart money in Asian rout  Economic Times1 day ago India drugmaker stocks exception in Asian rout  Money Control1 day ago Dr Reddy's, Britannia to get astro support: Gupta  Money Control1 month ago
[x]  

GLAXOSMITHKL 6128.25

GLENMARK PHA 1066.75 GMR INFRASTR 11.27 GODREJ CONS 1304.95 GODREJ IND 366.75 GODREJ PROP 302.30 GPPL 180.10 GRASIM IND. 3426.30 GREAT EASTE 369.50 GRUH FINANCE 250.70 GUJ PETRONET 119.80 GUJ.MINERAL 72.65 GUJ.ST.FERT 65.25 GVK POWERINF 6.98 HATHWAY CAB 40.80 ...
 Sify1 day ago GLAXOSMITHKL 6210.90  Sify2 weeks ago GLAXOSMITHKL 6277.25  Sify3 weeks ago GLAXOSMITHKL 6296.15  Sify4 weeks ago

Like Glenmark, Mindtree, Persistent Systems: R Sreesankar

R Sreesankar, Head - Institutional Equities at Prabhudas Lilladher likes Glenmark Pharma, Mindtree, Persistent Systems, Jubilant Lifesciences and JK Lakshmi Cement from the midcap space.
 Money Control1 day ago Pick Persistent Systems, YES Bank, Glenmark: R Sreesankar  Money Control2 months ago
Moneycontrol.com

Buy Glenmark Pharma, advises Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com recommends buying Glenmark Pharma as the stock could embark on a new upmove.
 Money Control4 days ago Buy Lupin, Glenmark Pharma on dips: Sudarshan Sukhani  Money Control2 weeks ago Buy Glenmark, has potential to reach higher levels: Sukhani  Money Control3 weeks ago Investors should consider buying Glenmark Pharma: Sukhani  Money Control1 month ago
NDTV Profit

MSCI: Glenmark, Indiabulls Housing In, JSPL Out Effective Today

Jindal Steel and Power will make way for the addition of drugmaker Glenmark and realty developer Indiabulls Housing to MSCI's India index effective Monday. The rebalancing will lead to buying of $94 million in Glenmark and $106 million in Indiabulls ...
 NDTV Profit4 days ago Investors eye Indiabulls Housing, Glenmark, Britannia for inclusion in MSCI indexes  Economic Times3 weeks ago Britannia, Glenmark, Indiabulls Housing likely to enter MSCI index  Economic Times3 weeks ago Britannia, Glenmark likely to enter MSCI index  Economic Times3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - glenmark
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less